Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease-results of the Immune Metabolic Associations in Psoriatic Arthritis study-论文-万方医学网

首页> > Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease-results of the Immune Metabolic Associations in Psoriatic Arthritis study

Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease-results of the Immune Metabolic Associations in Psoriatic Arthritis study

导出原文传递

翻译打印收藏纠错

第一作者： Ferguson, Lyn D.

作者： Ferguson, Lyn D. ^[1] ; Cathcart, Susanne ^[2] ; Rimmer, Dominic ^[3] ; Semple, Gary ^[4] ; Brooksbank, Katriona ; Paterson, Caron ; Brown, Rosemary ; Harvie, John ; Gao, Xuan ; Radjenovic, Aleksandra ; Welsh, Paul ; McInnes, Iain B. ; Sattar, Naveed ; Siebert, Stefan

作者单位： Inst Cardiovasc & Med Sci,Univ Glasgow ^[1] Glasgow Clin Res Facil,Glasgow Royal Infirm ^[2] Inst Infect Immun & Inflammat,Univ Glasgow ^[3] Raigmore Hosp ^[4]

关键词 apremilast PDE4 inhibition weight metabolic vascular adipose tissue ectopic fat psoriatic disease POOLED ANALYSIS PHASE-III WEIGHT ESTEEM ATHEROSCLEROSIS ROFLUMILAST

发布时间 2022-07-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease-results of the Immune Metabolic Associations in Psoriatic Arthritis study

相似文献

同项目论文

相关期刊

检索历史 清除

Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease-results of the Immune Metabolic Associations in Psoriatic Arthritis study

相似文献

同项目论文

相关期刊

检索历史清除